US 7928062
Methods for selectively inhibiting Janus tyrosine kinase 3 (Jak3)
granted A61KA61K31/335A61P
Quick answer
US patent 7928062 (Methods for selectively inhibiting Janus tyrosine kinase 3 (Jak3)) held by The Board of Regents of the University of Texas System expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Apr 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/335, A61P, A61P35/00, A61P35/02